@article{177bb6b282784551b8d87420df989005,
title = "Psilocybin for depression",
author = "Joshua Wiley and Bei Bei",
note = "Funding Information: Dr. Gr{\"u}nder reports serving as a consultant for Allergan, Boehringer Ingelheim, the Institute for Quality and Efficiency in Health Care, JanssenCilag, Lundbeck, Otsuka, Recordati, Sage, and Takeda; receiving speaking fees from Gedeon Richter, Janssen Cilag, Lundbeck, Otsuka, and Recordati; receiving grant support from Boehringer Ingelheim, Lundbeck, and Saladax; being cofounder of and shareholder in the Mind and Brain Institute, Brainfoods, and OVID Health Systems; and being a shareholder in the MIND Foundation. No other potential conflict of interest relevant to this letter was reported. Funding Information: Dr. Hieronymus reports receiving grants from the Lundbeck Foundation (R30320183429) and speaking fees from Lundbeck and Servier; and Dr. {\O}stergaard, receiving grants from the Lundbeck Foundation (R35820202341 and R34420201073) and the 2020 Lundbeck Foundation Young Investigator Prize. No other potential conflict of interest relevant to this letter was reported. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = aug,
day = "26",
doi = "10.1056/NEJMc2108082",
language = "English",
volume = "385",
pages = "862",
journal = "The New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "9",
}